Aposhian MM - Search Results

1

Aposhian HV, Aposhian MM. Aposhian HV, et al. Among authors: aposhian mm. Chem Res Toxicol. 2006 Jan;19(1):1-15. doi: 10.1021/tx050106d. Chem Res Toxicol. 2006. PMID: 16411650 Review. No abstract available.

2

Vitamin C, glutathione, or lipoic acid did not decrease brain or kidney mercury in rats exposed to mercury vapor.

Aposhian HV, Morgan DL, Queen HL, Maiorino RM, Aposhian MM. Aposhian HV, et al. Among authors: aposhian mm. J Toxicol Clin Toxicol. 2003;41(4):339-47. doi: 10.1081/clt-120022000. J Toxicol Clin Toxicol. 2003. PMID: 12870874

3

meso-2,3-Dimercaptosuccinic acid: chemical, pharmacological and toxicological properties of an orally effective metal chelating agent.

Aposhian HV, Aposhian MM. Aposhian HV, et al. Among authors: aposhian mm. Annu Rev Pharmacol Toxicol. 1990;30:279-306. doi: 10.1146/annurev.pa.30.040190.001431. Annu Rev Pharmacol Toxicol. 1990. PMID: 2160791 Review.

4

Mobilization of heavy metals by newer, therapeutically useful chelating agents.

Aposhian HV, Maiorino RM, Gonzalez-Ramirez D, Zuniga-Charles M, Xu Z, Hurlbut KM, Junco-Munoz P, Dart RC, Aposhian MM. Aposhian HV, et al. Among authors: aposhian mm. Toxicology. 1995 Mar 31;97(1-3):23-38. doi: 10.1016/0300-483x(95)02965-b. Toxicology. 1995. PMID: 7716789 Review.

5

DMPS-arsenic challenge test. II. Modulation of arsenic species, including monomethylarsonous acid (MMA(III)), excreted in human urine.

Aposhian HV, Zheng B, Aposhian MM, Le XC, Cebrian ME, Cullen W, Zakharyan RA, Ma M, Dart RC, Cheng Z, Andrewes P, Yip L, O'Malley GF, Maiorino RM, Van Voorhies W, Healy SM, Titcomb A. Aposhian HV, et al. Among authors: aposhian mm. Toxicol Appl Pharmacol. 2000 May 15;165(1):74-83. doi: 10.1006/taap.2000.8922. Toxicol Appl Pharmacol. 2000. PMID: 10814555

6

Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic.

Aposhian HV, Gurzau ES, Le XC, Gurzau A, Healy SM, Lu X, Ma M, Yip L, Zakharyan RA, Maiorino RM, Dart RC, Tircus MG, Gonzalez-Ramirez D, Morgan DL, Avram D, Aposhian MM. Aposhian HV, et al. Among authors: aposhian mm. Chem Res Toxicol. 2000 Aug;13(8):693-7. doi: 10.1021/tx000114o. Chem Res Toxicol. 2000. PMID: 10956055

7

Urinary mercury after administration of 2,3-dimercaptopropane-1-sulfonic acid: correlation with dental amalgam score.

Aposhian HV, Bruce DC, Alter W, Dart RC, Hurlbut KM, Aposhian MM. Aposhian HV, et al. Among authors: aposhian mm. FASEB J. 1992 Apr;6(7):2472-6. doi: 10.1096/fasebj.6.7.1563599. FASEB J. 1992. PMID: 1563599

8

Tissue decorporation of polonium-210 in rats by DMPA.

Aposhian HV, Dart RC, Aposhian MM, Dawson BV. Aposhian HV, et al. Among authors: aposhian mm. Res Commun Chem Pathol Pharmacol. 1987 Nov;58(2):157-71. Res Commun Chem Pathol Pharmacol. 1987. PMID: 2827276

9

Determination and metabolism of dithiol chelating agents. XV. The meso-2,3-dimercaptosuccinic acid-cysteine (1:2) mixed disulfide, a major urinary metabolite of DMSA in the human, increases the urinary excretion of lead in the rat.

Maiorino RM, Aposhian MM, Xu ZF, Li Y, Polt RL, Aposhian HV. Maiorino RM, et al. Among authors: aposhian mm, aposhian hv. J Pharmacol Exp Ther. 1993 Dec;267(3):1221-6. J Pharmacol Exp Ther. 1993. PMID: 8263783

10

Sodium 2,3-dimercapto-1-propanesulfonate (DMPS) treatment does not redistribute lead or mercury to the brain of rat.

Aposhian MM, Maiorino RM, Xu Z, Aposhian HV. Aposhian MM, et al. Toxicology. 1996 May 3;109(1):49-55. doi: 10.1016/0300-483x(96)03308-2. Toxicology. 1996. PMID: 8619252

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page